Inmune Bio annual debt-to-assets ratio
2019
2020
2021
2022
2023
2024
2025
Inmune Bio Debt-to-Assets Ratio Growth & History (INMB)
Inmune Bio's debt-to-assets ratio was 0.03 for fiscal 2025.
View full Inmune Bio company overviewInmune Bio annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.03 | 0.02 | +229.29% |
| 2024 | 2024-12-31 | 0.01 | −0.17 | −94.70% |
| 2023 | 2023-12-31 | 0.18 | 0.05 | +38.21% |
| 2022 | 2022-12-31 | 0.13 | −0.03 | −16.07% |
| 2021 | 2021-12-31 | 0.16 | 0.15 | +1856.53% |
| 2020 | 2020-12-31 | 0.01 | 0.00 | +17.20% |
| 2019 | 2019-12-31 | 0.01 | — | — |
Inmune Bio quarterly debt-to-assets ratio
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.05 | 0.04 | +337.31% |
| Q1 2026 | 2026-03-31 | 0.06 | — | — |
| Q4 2025 | 2025-12-31 | 0.03 | — | — |
| Q3 2025 | 2025-09-30 | 0.03 | −0.02 | −41.34% |
| Q2 2025 | 2025-06-30 | 0.01 | −0.09 | −88.44% |
| Q3 2024 | 2024-09-30 | 0.06 | −0.15 | −73.46% |
| Q2 2024 | 2024-06-30 | 0.10 | −0.12 | −53.62% |
| Q1 2024 | 2024-03-31 | 0.17 | −0.04 | −19.62% |
| Q4 2023 | 2023-12-31 | 0.18 | 0.05 | +38.21% |
| Q3 2023 | 2023-09-30 | 0.21 | 0.02 | +10.62% |
| Q2 2023 | 2023-06-30 | 0.22 | 0.04 | +24.39% |
| Q1 2023 | 2023-03-31 | 0.21 | 0.04 | +26.23% |
| Q4 2022 | 2022-12-31 | 0.13 | −0.03 | −16.07% |
| Q3 2022 | 2022-09-30 | 0.19 | 0.05 | +33.73% |
| Q2 2022 | 2022-06-30 | 0.18 | −0.06 | −24.82% |
| Q1 2022 | 2022-03-31 | 0.17 | 0.16 | +7818.90% |
| Q4 2021 | 2021-12-31 | 0.16 | 0.15 | +1856.53% |
| Q3 2021 | 2021-09-30 | 0.14 | 0.14 | +3751.94% |
| Q2 2021 | 2021-06-30 | 0.24 | 0.23 | +3510.58% |
| Q1 2021 | 2021-03-31 | 0.00 | −0.01 | −71.07% |
| Q4 2020 | 2020-12-31 | 0.01 | 0.00 | +17.20% |
| Q3 2020 | 2020-09-30 | 0.00 | −0.00 | −50.62% |
| Q2 2020 | 2020-06-30 | 0.01 | −0.00 | −1.39% |
| Q1 2020 | 2020-03-31 | 0.01 | — | — |
| Q4 2019 | 2019-12-31 | 0.01 | — | — |
| Q3 2019 | 2019-09-30 | 0.01 | — | — |
| Q2 2019 | 2019-06-30 | 0.01 | — | — |
Inmune Bio debt-to-assets ratio trends
Over the last five fiscal years, Inmune Bio's debt-to-assets ratio increased from 0.01 to 0.03, a change of 0.02. The latest reported quarter, Q2 2026, shows 0.05.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Inmune Bio source filings ↗